Potential therapeutic and pharmacological strategies for SARS-CoV2

被引：0
|
作者：
Doaa A. Ghareeb
Samar R. Saleh
Mohammed S. Nofal
Mohamed M. Y. Kaddah
Salma. F. Hassan
Inas K. Seif
Sally A. El-Zahaby
Shaimaa M. Khedr
Marwa Y. Kenawy
Aliaa A. Masoud
Salma A. Soudi
Ahmed A. Sobhy
Jaillan G. Sery
Miral G. Abd El-Wahab
Alshimaa A. Abd Elmoneam
Abdulaziz Mohsen Al-mahallawi
Maha A. El-Demellawy
机构：
[1] Alexandria University,Biological Screening and Preclinical Trial Laboratory, Department of Biochemistry, Faculty of Science
[2] City of Scientific Research and Technological Applications (SRTA-City),Pharmaceutical and Fermentation Industries Development Centre (PFIDC)
[3] Pharos University in Alexandria,Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy
[4] City of Scientific Research and Technological Applications (SRTA-City),Fabrication Technology Department, Advanced Technology and New Materials Research Institute (ATNMRI)
[5] Alexandria University,Clinical Pharmacy Program, Faculty of Pharmacy
[6] Cairo University,Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy
[7] October University for Modern Sciences and Arts (MSA),Department of Pharmaceutics, Faculty of Pharmacy
[8] GEBRI,Medical Biotechnology Department
[9] SRTA-City,undefined
来源：
Journal of Pharmaceutical Investigation | 2021年 / 51卷
关键词：
COVID-19; Hydroxychloroquine; Indomethacin; Tocilizumab; Teicoplanin; Camostat;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：281 / 296
页数：15
相关论文
共 50 条
  • [1] Potential therapeutic and pharmacological strategies for SARS-CoV2
    Ghareeb, Doaa A.
    Saleh, Samar R.
    Nofal, Mohammed S.
    Kaddah, Mohamed M. Y.
    Hassan, Salma. F.
    Seif, Inas K.
    El-Zahaby, Sally A.
    Khedr, Shaimaa M.
    Kenawy, Marwa Y.
    Masoud, Aliaa A.
    Soudi, Salma A.
    Sobhy, Ahmed A.
    Sery, Jaillan G.
    El-Wahab, Miral G. Abd
    Elmoneam, Alshimaa A. Abd
    Al-mahallawi, Abdulaziz Mohsen
    El-Demellawy, Maha A.
    JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2021, 51 (03) : 281 - 296
  • [2] Rerouting therapeutic peptides and unlocking their potential against SARS-CoV2
    Prashar, Namrata
    Mohammed, Saharuddin Bin
    Raja, N. S.
    Mohideen, Habeeb Shaik
    3 BIOTECH, 2025, 15 (05)
  • [3] From SARS-CoV to SARS-CoV2: a potentia guide to better understanding of pathophysiology of the disease and potential therapeutic modality
    Pashaki, P. Abbasi
    Roudkenar, M. Habibi
    Rahim, F.
    Ebrahimi, A.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (14) : 7816 - 7825
  • [4] Food spices as potential therapeutic agents in targeting inflammatory cytokine storm: A review on underlying mechanisms and therapeutic targeting strategies for SARS-CoV2
    Rathod, Priyanka
    Yadav, Raman P.
    INDIAN JOURNAL OF NATURAL PRODUCTS AND RESOURCES, 2023, 14 (02): : 185 - 201
  • [5] SARS-CoV2 pandemic: SARS-CoV2 seroprevalence and impact on HIV suppression in PLWH
    Cuomo, G.
    Bacca, E.
    Menozzi, M.
    Carli, F.
    Borghi, V.
    Guaraldi, G.
    Mussini, C.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2020, 23 : 111 - 112
  • [6] Neuromodulatory effects of SARS-CoV2 infection: Possible therapeutic targets
    Kumar, Sonali
    Shanker, Ozasvi R.
    Kumari, Neeraj
    Tripathi, Manjari
    Chandra, P. Sarat
    Dixit, Aparna Banerjee
    Banerjee, Jyotirmoy
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2021, 25 (06) : 509 - 519
  • [7] In silico Study of Pharmacological Treatments against SARS-CoV2 Main Protease
    Kadil, Youness
    Mouhcine, Mohamed
    Filali, Houda
    JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2020, 14 : 1065 - 1071
  • [8] Humoral Immune Responses to SARS-CoV2 Infections and upon Vaccination Against SARS-CoV2
    Finzel, Stephanie
    Peter, Nicole
    Brand, Chiara
    Fischer, Beate
    Keller, Barbel
    Weigang, Sebastian
    Kochs, Georg
    Schwemmle, Martin
    Rieg, Siegbert
    Mathe, Philipp
    Kern, Winfried
    van der Hoek, Lia
    de la Rosa, Kathrin
    Jack, Hans-Martin
    Warnatz, Klaus
    Voll, Reinhard
    Eibel, Hermann
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 12 - 13
  • [9] Ibuprofen and thromboembolism in SARS-COV2
    Arjomandi Rad, Arian
    Vardanyan, Robert
    Tas, Natalie R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (09) : 2425 - 2427
  • [10] To screen, or not to screen for SARS-Cov2
    Muula, Adamson S.
    MALAWI MEDICAL JOURNAL, 2020, 32 (02) : 52 - 53
12345